EMEA-001142-PIP02-16 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: P/0552/2022
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Zerbaxa
ceftolozane
tazobactam
Bacterial Infections
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
EMEA-001142-PIP01-11-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: P/0436/2020
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Milaxyn Plus - referral
praziquantel
pyrantel
febantel
Article 34
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralVeterinary